Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study focuses to prove the equivalent efficacy of two different Dexpanthenol formulations.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1 | Experimental |
| |
| Arm 2 | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexpanthenol foam spray, new formulation | Drug | 2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter |
|
| Measure | Description | Time Frame |
|---|---|---|
| Global sum of scores for evaluating the cooling/soothing effect evaluated after first and second application | 2 min, 5 min, 10 min, 15 min |
| Measure | Description | Time Frame |
|---|---|---|
| Skin temperature | 2 min, 5 min, 10 min | |
| Evaluation of the cooling/soothing effect (scores) after first and second application | 2 min, 5min, 10 min, 15 min | |
| Evaluation of the foam covering properties after first application |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Villeurbanne | 69503 | France |
Not provided
| ID | Term |
|---|---|
| D004890 | Erythema |
| ID | Term |
|---|---|
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012877 | Skin Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dexpanthenol foam spray, old formulation | Drug | 2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter |
|
| 2 min, 5 min, 10 min, 15 min |
| Incidence of adverse events | FPFV - LPLV |
| D013568 | Pathological Conditions, Signs and Symptoms |